by shannon@kinsdesign.co | Mar 23, 2026 | Press Releases
Abselion Appoints Dale Gordon as Chair Bioprocessing leader to drive continued commercial development and international expansion Cambridge, UK, and Cambridge, US, 23 March 2026: Abselion, a pioneering life sciences technology company focused on simplifying...
by shannon@kinsdesign.co | Mar 9, 2026 | Press Releases
Abselion Establishes US Subsidiary in Cambridge, MA Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform Cambridge, UK, and Cambridge, US, 9 March 2026: Abselion, a...
by shannon@kinsdesign.co | Nov 10, 2025 | Press Releases
Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025 Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across...
by shannon@kinsdesign.co | Sep 22, 2025 | Press Releases
Abselion Introduces Protein G Total Antibody Quantification Kit New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform Cambridge, UK, 22 September 2025: Abselion, a pioneering life sciences technology...
by shannon@kinsdesign.co | Sep 9, 2025 | Press Releases
Abselion Launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for...
by shannon@kinsdesign.co | Mar 4, 2025 | Press Releases
Abselion is delighted to announce the appointment of Kim Orton-Smith as Vice President of Sales & Marketing. Kim brings 19 years of global commercial experience in life sciences, with a track record of turning product innovation into scalable revenues and driving...
